Establish FeNO cut-off value for predicting Budesonide-formoterol response in chronic cough suggestive of CVA patients.

Trial Identifier: D589BL00076
Sponsor: AstraZeneca
Start Date: October 2024
Primary Completion Date: September 2025
Study Completion Date: September 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100034
CN Beijing, CN, 100029
CN Benxi, CN, 117000
CN Chengdu, CN, 610014
CN Chengdu, CN, 610041
CN Chongqing, CN, 400000
CN dongguan, CN, CN-523326
CN Fenyang, CN, 032299
CN fuzhou, CN, 350005
CN Guangzhou, CN, 510163
CN Guangzhou, CN, 510515
CN Guangzhou, CN, 510000
CN Guiyang, CN, 550002
CN Heifei, CN, 230011
CN Heze, CN, 274400
CN Huizhou, CN, 516002
CN Jiaxing, CN, 314001
CN Jinhua, CN, 321000
CN Liuzhou, CN, 545006
CN Nanchang, CN, 330006
CN Nanjing, CN, 211100
CN Nanyang, CN, 473000
CN quanzhou, CN, 362000
CN Shanghai, CN, 201114
CN Shanghai, CN, 310000
CN Shangqiu, CN, 476100
CN Shenzhen, CN, 518020
CN Shijiazhuang, CN, 050001
CN Suzhou, CN, 657299
CN Taiyuan, CN, 030001
CN Taiyuan, CN, 030032
CN Weifang, CN, 261000
CN Wenzhou, CN, 325000
CN Wenzhou, CN, 325027
CN Xi'an, CN, 710006
CN Xiangtan, CN, 411228
CN Yantai City, CN, 264000
CN Zhengzhou City, CN, 450000
CN Zunyi, CN, 563100